1998•Journal watchRequires access

Another Cholinesterase Inhibitor for Alzheimer's Disease.

AS Brett

Abstract

Cholinergic drugs can enhance cognitive function in Alzheimer's disease (AD), which is characterized by central cholinergic deficiency. Two randomized,

About this research paper

What this paper is about

Cholinergic drugs can enhance cognitive function in Alzheimer's disease (AD), which is characterized by central cholinergic deficiency. Two randomized,

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Cholinergic drugs can enhance cognitive function in Alzheimer's disease (AD), which is characterized by central cholinergic deficiency. Two randomized,

Key concepts: Cholinesterase, Medicine, Disease, Rivastigmine, Alzheimer's disease, Dementia, Pharmacology, Internal medicine

Back to paper search Browse research topics Original source

Another Cholinesterase Inhibitor for Alzheimer's Disease. — Research Paper | ScholarLens

Another Cholinesterase Inhibitor for Alzheimer's Disease.

About this research paper

What this paper is about

Why it matters

Key contribution

Method / approach

Main findings

Limitations

Applications

Available abstract

Related papers